Naqshadeynta cusub ee R & D

MIS | Casriyeynta tikniyoolajiyadda - faa'iidooyinka teknolojiyada - natiijooyinka qalliinka ka dib | czditech

Nidaamka laf-dhabarka ee ugu yar (MIS) waa tikniyoolajiyad-farshaxanka-farshaxanka oo u suurta geliya daweynta saxda ah iyada oo loo marayo meela yar oo lagu jaro xaaladaha sida disks-ka ah iyo stenosis laf-dhabarka.

Faahfaahinta naqshadeynta cusub

Faa'iido badan oo faafaya

Dhaawac yar

Naqshadeynta yar ee la jeexjeexay:

Meelaha caadiga ah waa kaliya 1-2 cm, yareynta muruqyada muruqyada iyo burburka unugyada jilicsan.

Teknolojiyada meeleeyaha saxda ah:

Si sax ah u hagaajiyay meelaynta meelaynta mushaharka leh ee ku-meel-gaarka ah (tusaale ahaan o-gacanta, 3d-c-cr) ama kaalmo robotic ah (tusaale ahaan Mazor x, Glous.

Dhiigbax-dhimista si kadis ah:

Tikniyoolajiyadda ugu yar ee is-weydaarsiga ayaa yareynaya halista dhaawaca xididdada, gaar ahaan waayeelka ama bukaannada comporbidd.

Dib u soo kabasho dhakhso leh

Isbitaalka Saqafka Gaadhiga:

Bukaanka badankood waa laga saaraa 24-48 saacadood qalliinka ka dib, marka la barbar dhigo 3-5 maalmood qalliinka furaha ee caadiga ah.

Dhaqdhaqaaqa Hore:

Xanuun yar oo ka sii fiican ilaalinta muruqyada ayaa u oggolow bukaanka inay si dhakhso leh ugu laabtaan hawlahooda maalinlaha ah.

Kordhinta biombanical

Codsiyada aqalka cusub:

Tusaale

Nidaamyada xasilinta firfircoon:

Maaneerata qaar ka mid ah

Tusmooyinka la ballaariyey

Daboolida cuduro badan oo spinal ah sida cudurka diskiga disc, ee laf-dhabarka lumbar, stenosis lumbar, spondylolisisthesis iyo jajabka vertebral.

临床案列

Kuwa soo socdaa waa kiisaska cilmi baarista ee wakiilada sannadihii ugu dambeeyay:

1. Tijaabada la xakameeyay ee la xakameynayo ee furitaanka laf-dhabarka ee Lumbur (TLIF)

Naqshadeynta Daraasadda:

Multiclenter mugga ah ee RCT (2022) isbarbardhiga MIS - TLIF (si yaryar oo lagu faafiyo) oo leh tlif furan.

Tirada muunad:

120 bukaan oo qaba hal-qaybiyo hal-abuur ah ayaa cudurka lafdhabarta ah.

Natiijooyinka:

Waqtiga qalliinka:

In yar oo badan kooxda MIS (celcelis ahaan 150 min vs. 130 daqiiqo), laakiin 60% dhiigbax yar (<100 ml vs. 250 ml).

Xanuunka kadib:

50% dhimista VAs dhibcaha 1 isbuuc ka dib markii ay ka dhigan tahay kooxda MIS, farqi weyn uma dhexeeyo labada koox kadib 3 bilood kadib.

Heerka Fusion:

1 sano kadib CT-ga kadib ayaa muujisay> 90% heerka isku-darka labada koox.

Dhibaatooyinka:

Infekshanka Infekshanka 2% ee MIS Proup vs. 8% kooxda furan.

2. Daraasad dabagal-dheer muddo dheer oo ku saabsan nidaamka xasilinta firfircoon (choflex)

Naqshadeynta Daraasadda:

Daraasadda dabagalka ee 5 sano ee Yurub (2021) Qiimaynta coflex murgacashada loogu talagalay daaweynta laf-dhabarka lumbar.

Tirada muunad:

80 bukaan ah.

Natiijooyinka:

Hagaajinta Shaqada:

ODI (Cansfunction Tusmada) ayaa hoos u dhacday 45 dhibcood oo ka dhacay Stanone ilaa 20 dhibcood 5 sano.

Qeybta deriska ah Nacadeynta:

Kaliya 12% bukaannada ayaa soo saaray dhibaatooyinka qeybta ku dhow, oo si weyn uga hooseeya qalalaasaha caadiga ah (~ 30%).

Heerka Dib-u-soo-noqoshada:

Isugeynta 5 sano ee dib-u-soo-noqoshada 8%, inta badan sababtuna tahay furitaanka (4%) ama astaamaha astaanta.

3. Daraasad mushahar leh oo lagu garto dadka robot-caawiyeyaasha

Naqshadeynta Daraasadda:

Daraasad dib-u-eegis ah oo lagu daabacay 2023 si loo falanqeeyo natiijooyinka meelaynta khaldan ee laga helo kaalmada robotic-ka Mazor.

Tirada muunad:

500 meelood oo meelaynta ah (daaqa thoracolagar).

Natiijooyinka:

Saxeex:

98.6% jagooyinka daboolka waxay ku qanacsanaayeen (Gertzbein-Robbins Creding A / B).

Dhibaatooyinka:

Heerka dhaawaca xididka dareeraha ah 0.4% marka loo eego 3-5% ee meelaynta caadiga ah ee bilaashka ah.

Aqoonta badeecada iyo faahfaahinta soosaarka badan, fadlan nala soo xiriir!